BSEBoard Meeting4d ago · 27 Jul 2026, 06:19 pm
Genesys International Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 ,inter alia, to consider and approve In continuation ....
Genesys International Corporation Ltd · 506109
✦ AI SummaryFundraise
Genesys International Corporation Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 to consider and approve the Rights Issue price, rights entitlement ratio, record date and other modalities related to the Rights Issue.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Genesys International Corporation Ltd - 506109 - Board Meeting Intimation for Meeting Of The Rights Issue Committee Of Genesys International Corporation Limited
Attachments (1)
📄pdf
Download →
6d25ec2e-efad-4863-9386-95db5bd97281.pdf
View document text
July 27, 2026
BSE Limited National Stock Exchange of India Ltd.
Corporate Relationship Department Exchange Plaza,
P.J. Towers, Bandra-Kurla Complex,
Dalal Street, Fort, Bandra (East)
Mumbai - 400 001 Mumbai - 400 051
Scrip Code: 506109 Symbol: GENESYS
Sub: Prior intimation of meeting of the Rights Issue Committee of Genesys
International Corporation Limited
Ref: Regulation 42 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015
Dear Sir/Madam,
In continuation to the meeting of the Board of Directors of Genesys International
Corporation Limited (the “Company”) held on Friday, June 26, 2026, approving the
Rights Issue of fully paid-up Equity shares of face value of ₹ 5 each to the eligible
Equity Shareholders of the Company, we would like to inform you that a meeting of
the Rights Issue Committee of the Board of Directors of the Company is scheduled
to be held on Friday, July 31, 2026, inter alia, to consider the Rights Issue price,
rights entitlement ratio, record date and other modalities related to the Rights
Issue.
We request you to take the above on record and disseminate the same on your
website.
Thanking You,
Yours Faithfully,
for Genesys International Corporation Limited
Kushal Jain
Company Secretary & Compliance Officer
Regd. Office: 73-A, SDF-III, SEEPZ, Andheri (E), Mumbai-400 096, India
Tel.: +91-22-2829 0303; +91-22-4488 4488; Fax: +91-22-2829 0603
Website: www.igenesys.com; E-mail:investors@igenesys.com
CIN: L65990MH1983PLC029197